ImmuPharma plcLSE: IMM

Appointment of Nomad

· Issued by ImmuPharma PLC
Immupharma PLC 16 November 2007 For Immediate Release 16 November 2007 ImmuPharma PLC Appointment of NOMAD and corporate broker ImmuPharma PLC (LSE:IMM), the specialist drug discovery and development company, is pleased to announce the appointment of Panmure Gordon & Co as its NOMAD and corporate broker with immediate effect. For further information, please contact: ImmuPharma PLC: 020 7152 4080 Richard Warr, Chairman Dimitri Dimitriou, Chief Executive Officer Panmure Gordon & Co: 020 7459 3600 Andrew Burnett This information is provided by RNS The company news service from the London Stock Exchange

ImmuPharma plc on 6ix

Earlier from ImmuPharma

Later from ImmuPharma

All ImmuPharma news releases